PDTs' Role in Addressing Health Care Disparities and Priorities for Improving PDT Access

Video content above is prompted by the following questions:

1. How can payers work with providers to establish protocols for appropriate PDT prescribing and monitoring efficacy?
2. What opportunities exist for collaborative demonstration projects across payers, providers, manufacturers, and other stakeholders to generate evidence on optimal implementation strategies?
3. How might PDTs potentially help mitigate or reduce healthcare disparities and inequities in access to treatment or health outcomes across different populations?
4. How important is it that Congress pass the Access to Prescription Digital Therapeutics Actas you consider the long-term value PDTs can have on improving care to patients?